Subclinical renal infection in pregnancy; pathogenesis, the organisms and the drugs of choice in its treatment.
D000667:Ampicillin / Q000627:therapeutic use; D001437:Bacteriuria / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D000013:Congenital Abnormalities / Q000209:etiology; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011704:Pyelonephritis / Q000188:drug therapy / Q000209:etiology; D013444:Sulfisoxazole / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy; D014556:Urine / Q000382:microbiology
D009268:Nalidixic Acid; D013444:Sulfisoxazole; D000667:Ampicillin; D009582:Nitrofurantoin